Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)

IMPORTANCE: No proven treatment is available for severely ill COVID-19. Therapeutic use of COVID-19 convalescent plasma (COPLA) is under investigation. OBJECTIVE: To compare the efficacy of COPLA with standard medical therapy (SMT) alone in severe COVID-19 patients. DESIGN, SETTING AND PARTICIPANTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajpai, Meenu, Maheshwari, Ashish, Dogra, Vikas, Kumar, Suresh, Gupta, Ekta, kale, Pratibha, Saluja, Vandana, Thomas, Sherin S, Trehanpati, Nirupama, Bihari, Chhagan, Agarwal, Reshu, Bharti, Praveen, Shankar, Prabha, Hussain, Javid, Chhabra, Karan, Gupta, Amita, Narayanan, Ashad, Agarwal, Sarika, Jain, Shruti, Bhardwaj, Ankit, Kumar, Guresh, Yadav, Birendra Kumar, Sarin, Shiv Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987237/
https://www.ncbi.nlm.nih.gov/pubmed/35387813
http://dx.doi.org/10.1136/bmjopen-2021-055189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987237/
https://www.ncbi.nlm.nih.gov/pubmed/35387813
http://dx.doi.org/10.1136/bmjopen-2021-055189

Ejemplares similares